1. Volume 71, Issue 2, Pages 168-171 (February 2017)
Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer 
Nicholas J. Vogelzang, Karim Fizazi, John M. Burke, Ronald De Wit, Joaquim Bellmunt, Thomas E. Hutson, Edward Crane, William R. Berry, Kevin Doner, John D. Hainsworth, Pawel J. Wiechno, Kejian Liu, Michelle F. Waldman, Anita Gandhi, Debora Barton, Ulf Jungnelius, Abderrahim Fandi, Cora N. Sternberg, Daniel P. Petrylak 
European Urology 
Volume 71, Issue 2, Pages (February 2017)
DOI: /j.eururo
Copyright © 2016 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan-Meier overall survival (OS) curves by baseline circulating tumor cell (CTC) count (≥5 cells/7.5ml blood vs <5 cells/7.5ml blood). NR=not reached.
European Urology  , DOI: ( /j.eururo )
Copyright © 2016 European Association of Urology Terms and Conditions